DLBS 2411

Drug Profile

DLBS 2411

Alternative Names: DLBS-2411

Latest Information Update: 06 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dexa Medica
  • Class Antiulcers
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Peptic ulcer

Most Recent Events

  • 02 May 2017 Phase-II trial is ongoing for Peptic ulcer in Indonesia (NCT02262169)
  • 16 Dec 2015 Biomarkers information updated
  • 01 May 2015 Phase-III clinical trials in Peptic ulcer in Indonesia (PO) (NCT02262169)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top